Orrstown Financial Services (ORRF) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
29 Jan, 2026Company overview and business model
Operates as a financial holding company for a wholly-owned bank subsidiary, providing banking and financial advisory services in south central Pennsylvania and parts of Maryland, Delaware, Virginia, West Virginia, and the District of Columbia.
Offers a range of products including common and preferred stock, depositary shares, debt securities, warrants, purchase contracts, and units, with flexibility to issue up to $200 million in aggregate value.
Use of proceeds and capital allocation
Net proceeds from securities sales are expected to be used for general corporate purposes, including capital contributions to the bank subsidiary, debt repayment, stock redemption, acquisitions, and other permitted activities.
Unused funds may be temporarily invested in securities or used to pay down borrowings.
Risk factors and disclosures
Faces risks from interest rate changes, economic conditions, competition, regulatory changes, credit quality, capital access, market volatility, cybersecurity, and operational risks.
Additional risks may arise from litigation, legal proceedings, and unforeseen events such as natural disasters or pandemics.
Investors are directed to review risk factors in the most recent Annual Report on Form 10-K and other SEC filings.
Latest events from Orrstown Financial Services
- Record earnings, strong loan growth, and higher dividend highlight robust 2025 results.ORRF
Q4 20253 Feb 2026 - Q1 2025 net income and EPS surged, with strong capital and lower merger costs.ORRF
Q1 202523 Dec 2025 - Major merger, robust financials, and key governance votes highlight this year's proxy.ORRF
Proxy Filing2 Dec 2025 - Q2 2025 saw higher earnings, improved efficiency, a dividend hike, and share repurchase authorization.ORRF
Q2 202516 Nov 2025 - Q3 2025 net income hit $21.9M, with record margins, strong growth, and robust capital.ORRF
Q3 20256 Nov 2025 - Q3 2024 loss from merger costs offset by strong adjusted earnings and loan growth.ORRF
Q3 202413 Jun 2025 - Q2 net income declined, but dividend rose 15% and Codorus merger integration is on track.ORRF
Q2 202413 Jun 2025 - Q4 2024 net income rebounded, merger integration completed, and cost savings achieved.ORRF
Q4 20245 Jun 2025